Naturhouse Health (NTH) | Financial Analysis & Statements
Naturhouse Health S.A.U. Mid-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2020Income Metrics
Revenue
12.0M
Gross Profit
8.6M
72.07%
Operating Income
4.4M
36.53%
Net Income
1.9M
16.01%
Balance Sheet Metrics
Total Assets
33.4M
Total Liabilities
15.7M
Shareholders Equity
17.8M
Debt to Equity
0.88
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2020
Annual Income Flow
2025
Naturhouse Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 47.6M | 49.4M | 50.4M | 52.4M | 57.6M |
| Cost of Goods Sold | 13.4M | 14.0M | 13.7M | 14.9M | 16.3M |
| Gross Profit | 34.3M | 35.5M | 36.7M | 37.5M | 41.3M |
| Gross Margin % | 72.0% | 71.8% | 72.8% | 71.5% | 71.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.0M | 3.4M | 2.7M | 3.5M | 3.9M |
| Other Operating Expenses | 6.8M | 6.7M | 6.0M | 7.9M | 6.6M |
| Total Operating Expenses | 9.8M | 10.1M | 8.7M | 11.4M | 10.6M |
| Operating Income | 13.2M | 13.1M | 16.3M | 12.8M | 17.5M |
| Operating Margin % | 27.8% | 26.6% | 32.3% | 24.5% | 30.5% |
| Non-Operating Items | |||||
| Interest Income | 211.0K | 542.0K | 43.0K | 111.0K | 361.0K |
| Interest Expense | 88.0K | 139.0K | 616.0K | 206.0K | 100.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 13.7M | 13.5M | 15.4M | 13.1M | 18.2M |
| Income Tax | 3.6M | 3.7M | 4.2M | 3.5M | 4.9M |
| Effective Tax Rate % | 26.3% | 27.2% | 27.0% | 26.6% | 26.7% |
| Net Income | 10.1M | 9.9M | 11.2M | 9.6M | 13.4M |
| Net Margin % | 21.2% | 20.0% | 22.3% | 18.4% | 23.2% |
| Key Metrics | |||||
| EBITDA | 14.7M | 16.1M | 18.3M | 15.6M | 21.0M |
| EPS (Basic) | - | €0.16 | €0.19 | €0.16 | €0.22 |
| EPS (Diluted) | - | €0.16 | €0.19 | €0.16 | €0.22 |
| Basic Shares Outstanding | - | 59949480 | 59949480 | 59949480 | 59949480 |
| Diluted Shares Outstanding | - | 59949480 | 59949480 | 59949480 | 59949480 |
Income Statement Trend
Naturhouse Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 13.4M | 20.7M | 24.4M | 12.1M | 27.2M |
| Short-term Investments | 1.0M | 991.0K | 2.7M | 2.7M | - |
| Accounts Receivable | 1.7M | 2.0M | 2.5M | 2.4M | 2.7M |
| Inventory | 2.9M | 3.4M | 2.8M | 2.7M | 2.6M |
| Other Current Assets | - | - | - | - | 779.0K |
| Total Current Assets | 19.6M | 28.2M | 34.4M | 27.1M | 37.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 370.0K | 371.0K | 444.0K | 609.0K | 753.0K |
| Intangible Assets | 370.0K | 371.0K | 444.0K | 609.0K | 753.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 13.8M | 14.4M | 14.5M | 15.8M | 11.7M |
| Total Assets | 33.4M | 42.6M | 48.8M | 42.8M | 49.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 3.1M | 3.6M | 4.1M | 3.4M | 3.2M |
| Short-term Debt | 526.0K | 880.0K | 1.4M | 1.2M | 894.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 11.9M | 6.5M | 12.8M | 8.4M | 8.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.9M | 2.2M | 1.8M | 2.1M | 1.3M |
| Deferred Tax Liabilities | 238.0K | 244.0K | 275.0K | 306.0K | 294.0K |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 3.8M | 4.4M | 5.5M | 6.6M | 4.9M |
| Total Liabilities | 15.7M | 10.9M | 18.2M | 15.0M | 12.9M |
| Equity | |||||
| Common Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
| Retained Earnings | 10.1M | 9.9M | 11.3M | 9.6M | 13.4M |
| Treasury Stock | 142.0K | 142.0K | 142.0K | 142.0K | 142.0K |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 17.8M | 31.7M | 30.6M | 27.9M | 36.1M |
| Key Metrics | |||||
| Total Debt | 2.4M | 3.0M | 3.2M | 3.3M | 2.2M |
| Working Capital | 7.7M | 21.7M | 21.6M | 18.7M | 29.2M |
Balance Sheet Composition
Naturhouse Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 13.7M | 13.5M | 15.4M | 13.1M | 18.2M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 639.0K | -350.0K | -417.0K | -3.4M | 1.8M |
| Operating Cash Flow | 14.0M | 14.2M | 15.6M | 9.8M | 19.8M |
| Investing Activities | |||||
| Capital Expenditures | 246.0K | 189.0K | 49.0K | 0 | - |
| Acquisitions | 0 | 0 | 0 | -4.4M | -3.5M |
| Investment Purchases | -194.0K | 0 | 0 | -692.0K | -703.0K |
| Investment Sales | 0 | 1.0M | 62.0K | 826.0K | 0 |
| Investing Cash Flow | 52.0K | 1.2M | 111.0K | -4.3M | -4.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -18.0M | -12.0M | -6.0M | -18.0M | -3.6M |
| Debt Issuance | - | - | - | 1.0M | - |
| Debt Repayment | -953.0K | -4.1M | -1.7M | - | -2.7M |
| Financing Cash Flow | -19.0M | -16.1M | -7.7M | -17.0M | -6.3M |
| Free Cash Flow | 11.7M | 11.2M | 20.4M | 6.1M | 16.1M |
| Net Change in Cash | -4.9M | -666.0K | 8.0M | -11.4M | 9.3M |
Cash Flow Trend
Naturhouse Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.00
Forward P/E
17.00
Price to Book
8.61
Price to Sales
3.21
PEG Ratio
17.00
Profitability Ratios
Profit Margin
21.19%
Operating Margin
23.84%
Return on Equity
40.83%
Return on Assets
21.77%
Financial Health
Current Ratio
1.65
Debt to Equity
19.30
Beta
0.35
Per Share Data
EPS (TTM)
€0.17
Book Value per Share
€0.30
Revenue per Share
€0.79
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NTH | 152.3M | 15.00 | 8.61 | 40.83% | 21.19% | 19.30 |
| Ebro Foods, S.A | 2.8B | 13.07 | 1.22 | 9.80% | 7.13% | 22.50 |
| Deoleo S.A | 164.5M | 16.45 | 0.76 | 4.65% | 1.15% | 36.99 |
| Coca-Cola | 36.5B | 19.15 | 4.67 | 22.89% | 9.29% | 130.00 |
| Puig Brands S.A | 2.5B | 27.29 | 3.83 | 48.50% | 9.12% | 71.01 |
| Distribuidora | 2.4B | 20.94 | 19.09 | 147.04% | 2.25% | 759.89 |
Financial data is updated regularly. All figures are in the company's reporting currency.





